Literature DB >> 31518043

Structural perspectives on HIV-1 Vif and APOBEC3 restriction factor interactions.

Farshad C Azimi1, Jeffrey E Lee1.   

Abstract

Human immunodeficiency virus (HIV) is a retroviral pathogen that targets human immune cells such as CD4+ T cells, macrophages, and dendritic cells. The human apolipoprotein B mRNA- editing catalytic polypeptide 3 (APOBEC3 or A3) cytidine deaminases are a key class of intrinsic restriction factors that inhibit replication of HIV. When HIV-1 enters the cell, the immune system responds by inducing the activation of the A3 family proteins, which convert cytosines to uracils in single-stranded DNA replication intermediates, neutralizing the virus. HIV counteracts this intrinsic immune response by encoding a protein termed viral infectivity factor (Vif). Vif targets A3 to an E3 ubiquitin ligase complex for poly-ubiquitination and proteasomal degradation. Vif is unique in that it can recognize and counteract multiple A3 restriction factor substrates. Structural biology studies have provided significant insights into the overall architectures and functions of Vif and A3 proteins; however, a structure of the Vif-A3 complex has remained elusive. In this review, we summarize and reanalyze experimental data from recent structural, biochemical, and functional studies to provide key perspectives on the residues involved in Vif-A3 protein-protein interactions.
© 2019 The Protein Society.

Entities:  

Keywords:  APOBEC3; HIV; lentivirus; protein-protein interactions; restriction factor; viral infectivity factor

Mesh:

Substances:

Year:  2019        PMID: 31518043      PMCID: PMC6954718          DOI: 10.1002/pro.3729

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  117 in total

1.  Rate4Site: an algorithmic tool for the identification of functional regions in proteins by surface mapping of evolutionary determinants within their homologues.

Authors:  Tal Pupko; Rachel E Bell; Itay Mayrose; Fabian Glaser; Nir Ben-Tal
Journal:  Bioinformatics       Date:  2002       Impact factor: 6.937

2.  Comparison of site-specific rate-inference methods for protein sequences: empirical Bayesian methods are superior.

Authors:  Itay Mayrose; Dan Graur; Nir Ben-Tal; Tal Pupko
Journal:  Mol Biol Evol       Date:  2004-06-16       Impact factor: 16.240

3.  Structural Insights into HIV-1 Vif-APOBEC3F Interaction.

Authors:  Masaaki Nakashima; Hirotaka Ode; Takashi Kawamura; Shingo Kitamura; Yuriko Naganawa; Hiroaki Awazu; Shinya Tsuzuki; Kazuhiro Matsuoka; Michiko Nemoto; Atsuko Hachiya; Wataru Sugiura; Yoshiyuki Yokomaku; Nobuhisa Watanabe; Yasumasa Iwatani
Journal:  J Virol       Date:  2015-11-04       Impact factor: 5.103

4.  Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein.

Authors:  Ann M Sheehy; Nathan C Gaddis; Jonathan D Choi; Michael H Malim
Journal:  Nature       Date:  2002-07-14       Impact factor: 49.962

5.  Selective assembly of HIV-1 Vif-Cul5-ElonginB-ElonginC E3 ubiquitin ligase complex through a novel SOCS box and upstream cysteines.

Authors:  Yunkai Yu; Zuoxiang Xiao; Elana S Ehrlich; Xianghui Yu; Xiao-Fang Yu
Journal:  Genes Dev       Date:  2004-12-01       Impact factor: 11.361

6.  Identification of a novel WxSLVK motif in the N terminus of human immunodeficiency virus and simian immunodeficiency virus Vif that is critical for APOBEC3G and APOBEC3F neutralization.

Authors:  Ying Dang; Xiaojun Wang; Tao Zhou; Ian A York; Yong-Hui Zheng
Journal:  J Virol       Date:  2009-06-17       Impact factor: 5.103

7.  A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor.

Authors:  Hal P Bogerd; Brian P Doehle; Heather L Wiegand; Bryan R Cullen
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-03       Impact factor: 11.205

8.  Direct evidence of extensive diversity of HIV-1 in Kinshasa by 1960.

Authors:  Michael Worobey; Marlea Gemmel; Dirk E Teuwen; Tamara Haselkorn; Kevin Kunstman; Michael Bunce; Jean-Jacques Muyembe; Jean-Marie M Kabongo; Raphaël M Kalengayi; Eric Van Marck; M Thomas P Gilbert; Steven M Wolinsky
Journal:  Nature       Date:  2008-10-02       Impact factor: 49.962

9.  Identification of amino acid residues in APOBEC3G required for regulation by human immunodeficiency virus type 1 Vif and Virion encapsidation.

Authors:  Hendrik Huthoff; Michael H Malim
Journal:  J Virol       Date:  2007-01-31       Impact factor: 5.103

10.  Structural determinants of HIV-1 Vif susceptibility and DNA binding in APOBEC3F.

Authors:  Karen K Siu; Azmiri Sultana; Farshad C Azimi; Jeffrey E Lee
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

View more
  7 in total

1.  High-speed atomic force microscopy directly visualizes conformational dynamics of the HIV Vif protein in complex with three host proteins.

Authors:  Yangang Pan; Luda S Shlyakhtenko; Yuri L Lyubchenko
Journal:  J Biol Chem       Date:  2020-06-24       Impact factor: 5.157

Review 2.  Structural perspectives on HIV-1 Vif and APOBEC3 restriction factor interactions.

Authors:  Farshad C Azimi; Jeffrey E Lee
Journal:  Protein Sci       Date:  2019-11-29       Impact factor: 6.725

3.  An Update on Antiretroviral Therapy.

Authors:  Luis Menéndez-Arias; Samara Martín-Alonso; Estrella Frutos-Beltrán
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Functional and Structural Insights into a Vif/PPP2R5 Complex Elucidated Using Patient HIV-1 Isolates and Computational Modeling.

Authors:  Daniel J Salamango; Jennifer L McCann; Özlem Demir; Jordan T Becker; Jiayi Wang; Jairam R Lingappa; Nuri A Temiz; William L Brown; Rommie E Amaro; Reuben S Harris
Journal:  J Virol       Date:  2020-10-14       Impact factor: 5.103

Review 5.  Dual Functionality of HIV-1 Vif in APOBEC3 Counteraction and Cell Cycle Arrest.

Authors:  Daniel J Salamango; Reuben S Harris
Journal:  Front Microbiol       Date:  2021-01-12       Impact factor: 5.640

Review 6.  Degradation-Independent Inhibition of APOBEC3G by the HIV-1 Vif Protein.

Authors:  Benjamin Stupfler; Cédric Verriez; Sarah Gallois-Montbrun; Roland Marquet; Jean-Christophe Paillart
Journal:  Viruses       Date:  2021-04-03       Impact factor: 5.048

Review 7.  Host Restriction Factors Modulating HIV Latency and Replication in Macrophages.

Authors:  Isabel Pagani; Pietro Demela; Silvia Ghezzi; Elisa Vicenzi; Massimo Pizzato; Guido Poli
Journal:  Int J Mol Sci       Date:  2022-03-11       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.